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Abstract
Celiac disease is a common autoimmune disease caused by sensitivity to the dietary protein gluten. Forty loci have been
implicated in the disease. All disease loci have been characterized as low-penetrance, with the exception of the high-risk
genotypes in the HLA-DQA1 and HLA-DQB1 genes, which are necessary but not sufficient to cause the disease. The very
strong effects from the known HLA loci and the genetically complex nature of the major histocompatibility complex (MHC)
have precluded a thorough investigation of the region. The purpose of this study was to test the hypothesis that additional
celiac disease loci exist within the extended MHC (xMHC). A set of 1898 SNPs was analyzed for association across the 7.6 Mb
xMHC region in 1668 confirmed celiac disease cases and 517 unaffected controls. Conditional recursive partitioning was
used to create an informative indicator of the known HLA-DQA1 and HLA-DQB1 high-risk genotypes that was included in the
association analysis to account for their effects. A linkage disequilibrium-based grouping procedure was utilized to estimate
the number of independent celiac disease loci present in the xMHC after accounting for the known effects. There was
significant statistical evidence for four new independent celiac disease loci within the classic MHC region. This study is the
first comprehensive association analysis of the xMHC in celiac disease that specifically accounts for the known HLA disease
genotypes and the genetic complexity of the region.
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Introduction
Celiac disease (gluten-sensitive enteropathy, celiac sprue) is
a common T cell auto-immune disease caused by sensitivity to the
dietary protein gluten. It is primarily a disease of Caucasians, with
a population prevalence of approximately 1% [1], with evidence
suggesting that it is increasing in incidence [2,3]. Co-occurrence of
celiac disease with other autoimmune diseases has been noted,
including type I diabetes, autoimmune thyroiditis, Sjo ¨gren’s
syndrome, Addison’s disease, alopecia areata, inflammatory bowel
disease, and adult rheumatoid arthritis [4,5,6,7].
The role of histocompatibility antigens in the major histocom-
patibility complex (MHC) in celiac disease was first reported 30
years ago [8,9] with the identification of HLA DQ2 almost 20
years ago [10]. Linkage studies to identify highly penetrant genes
were conducted, but other than at HLA, no consistent high-risk
loci were identified [11,12,13,14,15,16,17,18]. More recently,
genome-wide association studies (GWAS) and follow-up studies
have identified 39 non-HLA loci that are associated with celiac
disease, all together explaining approximately 5% of the disease
risk [19,20,21,22,23]. In GWAS, the strongest associations by
a large magnitude were to the MHC region, with the most strongly
associated SNP explaining approximately 35% of the disease risk.
The HLA class II molecules, particularly the DQ2 molecule
because of its unique peptide binding motif, are necessary for
celiac disease and encode for cell surface proteins on CD4+ T
lymphocytes that recognize gliadin [24]. The specific DQ
molecule that is expressed, i.e., the serotype, is determined by
the alleles present in the HLA-DQA1 and HLA-DQB1 HLA class
II genes. Greater than 90% of celiac disease cases express HLA
DQ2 [25,26,27,28]. Approximately 5% of celiac disease cases are
DQ8 [29,30,31], with the remaining 3–5% of celiac disease cases
carrying neither DQ8 nor DQ2, although most carry a DQB1*02
allele. However, the HLA association is necessary but not sufficient
for celiac disease to develop. Approximately 30% of the
population carries the HLA DQ2 genotype, yet only 1% of the
population develop the disease [32,33,34].
An investigation of the extended MHC (xMHC) for additional
disease-associated common variants has not been conducted.
Focused studies of the MHC in systemic lupus erythematosus
(SLE) [35] and type 1 diabetes (IDDM) [36,37,38] have found
evidence for novel, independent genetic associations in the region.
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studies are unique, the studies shared a common approach. The
known HLA disease alleles were characterized in an informative
way then included in the association analysis to account for the
known risk alleles while searching for new disease alleles. In this
study, taking a similar approach, we test the hypothesis that there
are additional disease-associated common variants in the HLA
region other than the known HLA-DQA1 and HLA-DQB1 disease
alleles.
Results
The 1898 SNPs spanning the xMHC were analyzed for
association with celiac disease with a simple logistic regression
model that included only the SNP genotype as the predictor of
disease. The purpose of this analysis was to assess the associations
between the 1898 SNPs and celiac disease without any statistical
adjustment for the known high-risk genotypes at the HLA-DQA1
and HLA-DQB1 genes. The results of the association analysis are
shown in Figure 1. The strongest association was found at
rs2647044 with many other SNPs showing significant association
near the HLA-DQA1 and HLA-DQB1 genes. SNP rs2647044 is
approximately 35 kb centromeric of HLA-DQB1 and 60 kb from
HLA-DQA1. Analysis of pairwise LD, measured by the r
2 value,
between rs2647044 and every other SNP showed that there were
no other SNPs among those tested that were strongly correlated
with the most significant SNP (Figure 1). The SNPs were expected
to show low r
2 values because they were drawn from an Illumina
GWAS platform and would have been selected for high
informativity and low redundancy. Recombination hotspots are
clearly apparent and delineate changes in the patterns of
association between the SNPs and disease (Figure 1).
With very strong association originating from the known HLA
high-risk genotypes it was impossible to identify independent SNP
associations, hence we first utilized a statistical procedure to
generate an informative categorical variable that marked the
known genotype effects, and then we included this categorical
variable in our logistic regression model. A categorical variable
was constructed by conditional recursive partitioning to account
for the HLA high-risk alleles. The common HLA genotypes
associated with the highest risk of developing celiac disease are
HLA-DQ2.5 and HLA-DQ8. The HLA-DQ2.2/7 genotypes also
result in HLA-DQ2.5 through in trans combination of haplotypes.
The HLA-DQA1 and HLA-DQB1 typing resulted in 16 possible
multi-locus genotype categories. A conditional inference tree
model based on the HLA-DQA1 and HLA-DQB1 genotypes was
computed that resulted in five terminal nodes (Figure 2). As
expected, the terminal nodes that were most informative of the
outcome were the DQ2.5 homozygotes (n=279 samples) followed
by heterozygotes with one copy of DQ2.5 and one non-DQ8
haplotype (n=1073), and the DQ2.5/DQ8 heterozygotes (n=148
samples). Information dropped off significantly for the final two
terminal nodes, with the worst case identification rate for those
samples with non-DQ2.5 and non-DQ8 haplotypes (n=470). The
recursive partitioning algorithm could not further split the node
representing samples with either 1 or 2 copies of the DQ8
haplotype (n=215). The tree model showed no evidence that the
effects of either the DQ2.5 or the DQ8 haplotypes were
multiplicative. Table 1 shows the frequency distribution of the
categorical variable created from the five terminal nodes of the
Figure 1. Association results for 1898 SNPs across xMHC, without accounting for the known HLA high-risk genotypes in the
statistical analysis. Vertical bars indicate recombination rates generated from HapMap database. All pairwise linkage disequilibrium coefficients (r
2)
included the most significantly associated SNP, rs2647044.
doi:10.1371/journal.pone.0036926.g001
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terminal nodes were significant at p-values less than 0.003.
The 1898 SNPs were each tested in a logistic regression model
that included the categorical variable as well as SNP rs1063355.
The SNP rs1063355 occurs in the 39 untranslated region (UTR) of
the HLA-DQB1 gene and it was included in the association model
because it is known to be strongly associated with the HLA-DQB1
high-risk allele and was among the GWAS SNPs. In logistic
regression model with rs1063355 as the only predictor of celiac
disease, the SNP had a p-value of less than 1.0610
217; however,
adding the computed categorical variable to the model resulted in
rs1063355 having a p-value of 2.5610
25, indicating relatively
weaker but significant residual effects on the disease outcome. The
purpose of including rs1063355 in the association model was to
eliminate the possibility of the SNP being identified as an
independent predictor of the disease, since it is already known,
and to account for any residual effects from HLA-DQB1 not
identified by the categorical variable. Figure 3a shows the results of
the association analysis, and demonstrate the impact of the
adjustment for the known HLA high-risk genotypes. While
rs2647044 (P=3.85610
220) was still highly significant,
rs9357152 (P=7.28610
224) became the most significantly asso-
ciated SNP when the effects from the known HLA high-risk
genotypes were accounted for in the logistic regression model. The
SNP rs2647044 is approximately 3.3 kb from rs935152. In
Figure 3b, focused on the HLA-DQA1 and HLA-DQB2 intergenic
region, several SNPs remained significantly associated within the
region of the known celiac DQA1 and DQB1 disease genes.
A SNP grouping method was carried out to identify a minimal
set of SNPs with independent effects on the disease across the
xMHC. This analysis used results from the association analysis
that accounted for the known HLA-DQA1 and HLA-DQB1 high-
risk genotype effects. Independent sets of SNPs were constructed
according to their correlated effects on the disease outcome, with
each set being identified by a single index SNP that was most
informative of the group and most strongly associated with disease.
Grouping was based on the following parameters: the significance
threshold for index SNPs of a p-value less than 5610
27;
a secondary significance for grouped SNPs of a p-value less than
Figure 2. Binary tree computed by conditional recursive partitioning on HLA-DQA1 and HLA-DQB1 genotypes.
doi:10.1371/journal.pone.0036926.g002
Table 1. Characteristics of Five-Level Variable for Known HLA
High-Risk Alleles Computed by Conditional Recursive
Partitioning.
Genotype Cases Controls Total
DQ2.5/DQ8 heterozygote 117 (0.07) 31 (0.06) 148 (0.07)
DQ2.5 homozygote 266 (0.16) 13 (0.03) 279 (0.13)
DQ2.5/non-DQ8 heterozygote 949 (0.57) 124 (0.24) 1073 (0.49)
1 or 2 copies of DQ8 124 (0.07) 91 (0.18) 215 (0.10)
non-DQ2.5/non-DQ8 212 (0.13) 258 (0.50) 470 (0.22)
Total 1668 (1.00) 517 (1.00) 2185 (1.00)
doi:10.1371/journal.pone.0036926.t001
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in the group can span; and an LD threshold, measured by r
2, of 0.1
or greater with the index SNP. The parameters were chosen to be
conservative such that the validity of the results was maximized.
An analysis was carried out to determine the relationships
between the parameter values used in the SNP grouping
procedure and the number of SNPs identified. As described in
the Methods section, the grouping procedure depends on several
user-defined input parameters. The purpose of this analysis was to
determine the sensitivity of the method to the input parameter
values so the values used in the subsequent grouping analysis were
not arbitrarily set. The analysis showed that the number of index
SNPs identified largely depended on the significance threshold for
the index SNP and the LD between the index SNP and the
secondary SNPs within each group. In Figure 4a, the linear
relationship between the numbers of index SNPs identified and the
r
2 parameter, with r
2 values ranging from 0.05 to 1.0 are shown. As
secondary SNPs are required to show greater r
2 values with the
index SNP, more groups containing fewer SNPs are formed,
resulting in more index SNPs. The relationship between the
number of index SNPs and the r
2 values between 0.01 and 0.15 is
shown in Figure 4b, where the number of index SNPs reaches
a minimum of six at an r
2 value of 0.07. The r
2 value was set at
0.10 as a tradeoff between the ability to distinguish independent
associations, while accepting that long-range LD is predominant
across the MHC and weak correlations between independently
acting loci are likely. The relationship between the significance
threshold for the index SNP [measured as 216log10 (p-value for
association)] and the number of index SNPs identified is shown in
Figure 4c. The number of index SNPs showed an exponential
decline as the index SNP statistical significance threshold increased
[i.e., the p-value decreases and 216log10 (p-value) increased],
with the parameter showing a declining impact on the number of
index SNPs at a p-value of 1.0610
26 [216log10 (p-value)=6].
The number of index SNPs will minimize at zero when the
threshold exceeds the statistical significance of all SNPs in the
experiment. The p-value threshold of 5.0610
27 [216log10 (p-
value)=7] was selected to be below the point at which the
parameter has a large effect on the number of index SNPs
identified but large enough that the procedure could select from
many putative independent loci. The analysis determined that the
secondary significance level and the physical distance parameters
had weak effects on the number of index SNPs identified (results
not shown).
The grouping procedure resulted in the identification of seven
index SNPs that showed independent effects on the celiac disease
outcome, in addition to the known HLA high-risk types that were
accounted for in the analysis. The positions of the seven loci across
the xMHC as well as the estimated rates of recombination are
shown in Figure 5. The seven loci all map within the classical
MHC region and are separated by hotspots of recombination. In
table 2, the seven index SNPs are ranked by their statistical
significance, with all seven showing p-values less than the defined
index SNP significance threshold of 5.0610
27. Four of the SNPs
had odds ratios greater than 1.0 indicating that the minor allele
was at increased frequency among cases, while the remaining three
SNPs showed the opposite effect and the more frequent allele was
predominant among cases. The top four most statistically
significant index SNPs (rs937152, rs204991, rs2523674 and
rs2517485) each tagged over 30 secondary SNPs with a combined
total of 135, while the remaining three index SNPs (rs2260000,
rs9276435 and rs2844776) tagged a combined total of 34
secondary SNPs (Table 2).
To further verify the independence of the seven index SNPs,
they were analyzed simultaneously for association in two multiple
logistic regression models. In the first model, the seven SNPs were
the only predictors of celiac disease. Table 2 shows that five of the
seven index SNPs remain statistically significant with p-
values,0.01 when they are modeled together. SNPs rs2260000
(p-value=0.23) and rs2844776 (p-value=0.052) were not signif-
icant predictors of the disease when analyzed simultaneously with
the other five SNPs. The second multiple logistic regression model
Figure 3. Association results for 1898 SNPs across (a) full xMHC, and (b) focused on the region around the known HLA class 2 celiac
disease genes, accounting for known HLA high-risk genotypes in the statistical analysis. Vertical bars indicate recombination rates
generated from HapMap database. All pairwise linkage disequilibrium coefficients (r
2) included the most significantly associated SNP, rs9357152.
doi:10.1371/journal.pone.0036926.g003
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variable for the known common HLA high-risk genotypes that was
computed by recursive partitioning. This analysis identified four of
the seven SNPs as being significant predictors of celiac disease
including, rs9357152 (p-value=0.00012), rs204991 (p-val-
ue=0.0024), rs2523674 (p-value=0.00693) and rs2517485 (p-
value=0.0022). Each of the four SNPs tagged more than thirty
other SNPs across the MHC region. The multiple logistic
regression analysis results showed that rs9357152, rs204991,
rs2523674 and rs2517485 were statistically significant independent
markers of new celiac disease loci within the MCH.
Figure 4. Results of sensitivity analysis for SNP grouping analysis showing the relationship between the group linkage
disequilibrium parameter (r
2) and the number of index SNPs identified, with r
2 ranging from (a) 0.05 to 0.95, and focused on the
range from (b) 0.01 to 0.15. Results (c) show the relationship between the minimum statistical significance parameter for the association between
the disease and the index SNP and the number of index SNPs identified.
doi:10.1371/journal.pone.0036926.g004
Figure 5. Association analysis results and locations of seven index SNPs identified by grouping analysis of the xMHC. Recombination
rates were estimated from HapMap data and are indicated by vertical bars.
doi:10.1371/journal.pone.0036926.g005
Association Study of Celiac Disease and the MHC
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GWAS have successfully identified 39 non-HLA loci showing
signficant association with celiac disease, with modest predictive
information [19,23]. Alleles of the HLA-DQA1 and HLA-DQB1
genes are necessary for celiac disease but are not sufficient for
disease development. The xMHC contains more than 250
expressed genes of which many are involved in immune-regulation
[39]. However, it had not been thoroughly interrogated for
additional celiac disease loci due to the complicated nature of the
analysis, including the very strong effects of the known disease
alleles, the extraordinary genetic variation within the region, and
the complex patterns of linkage disequilbrium. A simple associa-
tion analysis of the region that does not take these complications
into account would generate misleading results (as seen in our
comparison of simple and multiple logistic regression models).
Statistical evidence was presented for four new and independent
celiac disease susceptibility loci within the classical MHC. An
informative measure of the known high-risk HLA genotypes was
computed by recursive partitioning and coded as a categorical
variable. The variable was included in an association analysis of
the 7.6 Mb xMHC region using a set of 1898 SNPs that passed
rigorous quality control assessments. The conditional recursive
partitioning approach is superior to a sample stratification to
account for the known HLA high-risk types; there is not a loss of
power from sub-sampling, and it generates the most informative
measure of the known effect. The independent associations were
identified using a conservative grouping procedure that was
designed to minimize the probability of false positive results.
The recursive partitioning analysis generated a variable that
captured the effects of the known common HLA-DQA1 and HLA-
DQB1 high-risk genotypes on the disease outcome. Including the
variable in the association analysis had a pronounced effect on the
association results. Of the 671 SNPs that had p-values of less than
5.0610
27 without including the high-risk genotype effects, 48 had
p-values less than the threshold when the known HLA effects were
accounted for in the analysis model. While the adjustment for the
effects was effective, it is unlikely that it was complete. There are
low frequency risk alleles and genotypes at HLA-DQA1 and HLA-
DQB1 that were not specifically identified by the categorical
variable because they were not common enough to be strong
predictors of disease in the full sample. Furthermore, the complex
genetic structure of the MHC is not completely amenable to
straightforward statistical adjustment. Although residual influence
from HLA-DQA1 and HLA-DQB1 high-risk genotypes is likely to
exist, it is unlikely that the four independent disease loci identified
in the analysis are due to unaccounted for correlations with the
known HLA risk genotypes given the conservative approach that
was taken in the study. The results strongly suggest additional
celiac disease alleles are present in the MHC.
None of the SNPs reported in Table 2 occur in the coding
sequence of genes or have known or reported functional effects. In
Table 2, we list the functional genes that the SNPs occur within or
the closest gene that is within the same LD haplotype block. SNP
rs9357152, previously reported in a GWAS to be associated with
celiac disease [22], is on the same haplotype block as rs9469220,
which is associated with Crohn’s disease [40], and rs6457617,
which is associated with rheumatoid arthritis [41]. HLA-DQB1 is
the closest gene to rs9357152 at approximately 45 kb centromeric,
however moderate recombination separates the index SNP from
the gene. SNP rs204991 is in the third intron of the G-Protein
Signaling Modulator 3 gene (GPSM3), within a haplotype block
that encompasses the entire gene. HLA Complex P5 (HCP5) is the
nearest gene to rs2523674 at about 4 kb, no other genes are within
20 kb of the SNP. Another SNP in HCP5 was found to be
significantly associated with severe cutaneous adverse drug
reactions in a Japanese GWAS [42]. SNP rs2517485 is about
10 kb from the putative psoriasis and systemic sclerosis disease
susceptibility gene (SEEK1 or PSORS1C1) and the Corneodesmosin
Precursor gene (CDSN).
The goal of this analysis was to test the hypothesis that the
known HLA-DQA1 and HLA-DQB1 celiac disease high-risk alleles
were not the only celiac disease alleles within the xMHC. The
results show evidence for additional celiac disease loci within the
3.7 Mb classic MHC region, however no evidence was found for
additional disease loci within the additional 4.1 Mb of the
extended region. The index SNPs, rs9357152, rs204991,
rs2523674 and rs2517485, were the strongest markers for the
four new loci among the 1898 SNPs included in the analysis.
Additional investigation is required to validate the reported
findings and to locate the new disease alleles, including de-
termining if these SNPs are causal, possibly playing roles in
regulation of these genes, or if they are only tagging causal
variants.
Materials and Methods
Study subjects
As part of our GWAS study, we formed a North American
Celiac Disease Genetic consortium comprised of Dr. S. Neuhau-
Table 2. Association Results for Seven Index SNPs Representing Independent Loci.
SNP Position
Minor
allele
Minor
allele
freq. P-value
Odds ratio
(95% C.I.)
No.
Secondary
SNPs
Multiple LR
P-value
No HRA Adj.
#
Multiple LR
P-value
HRA Adj
Functional
Genes*
rs9357152 32664960 G 0.12 7.28610
224 0.24 (0.21–0.28) 34 0.0004 0.00012 HLA-DQB1
rs204991 32161366 G 0.46 1.13610
212 2.24 (2.00–2.51) 33 3.31610
29 0.0024 GPSM3
rs2523674 31436789 A 0.35 6.55610
210 0.57 (0.52–0.62) 33 0.0014 0.00693 HCP5
rs2517485 31074101 A 0.49 2.03610
29 1.77 (1.61–1.95) 35 6.53610
25 0.0022 SEEK1/PSORS1C1
rs2260000 31593476 G 0.22 5.90610
28 0.60 (0.54–0.66) 15 0.23 0.39 BAT2
rs9276435 32713867 A 0.40 3.28610
27 1.82 (1.62–2.05) 5 0.00014 0.10 HLA-DQA2
rs2844776 30171827 G 0.37 4.17610
27 1.65 (1.50–1.83) 4 0.052 0.096 TRIM26
*Either the gene that the SNP occurs in, or the nearest gene within the same LD haplotype block as the index SNP.
#Indicates adjustment for known common high-risk alleles by inclusion of the five-level variable computed by recursive partitioning.
doi:10.1371/journal.pone.0036926.t002
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Mayo Clinic, Dr. A. Fasano at the University of Maryland, and
Dr. P. Green at Columbia University to study subjects enrolled in
previous studies at each center. The already collected, coded, non-
identifiable samples were contributed from City of Hope, Mayo
Clinic, University of Maryland and Columbia University. The
City of Hope Institutional Review Board approval was granted in
January 2010, and the approved protocol is 09169. The Mayo
Clinic participants were previously enrolled under the direction of
Dr. Joseph Murray under an approved IRB protocol 1173-99.
Similarly, the samples from the University of Maryland were
collected under the direction of Dr. Alessio Fasano under three
approved IRB protocols (H- 27784, H29090, and H-29938).
Similarly, the samples from Columbia University were collected
under the direction of Dr. Peter Green under approved IRB
protocol AAAE8893 (and previous protocol #8562). All partici-
pants provided written informed consent as described in each of
the protocols.
Reflecting the population of celiac disease, all 2300 participants
were Caucasian. Of the celiac disease cases, 532 were from COH,
743 from the Mayo Clinic, 423 from the University of Maryland,
and 66 from Columbia University. Of the controls, 177 were from
COH and 359 from the Mayo Clinic, for a total of 1764 cases and
536 controls. Blood samples were collected for serology testing for
celiac disease and DNA was extracted for genetic studies. The four
sites used the same serological tests, collected similar questionnaire
data, and used the same criteria for diagnosis of celiac disease. To
be defined as celiac disease, each case was required to have: 1)
positive celiac-specific autoantibody (IgA EMA and IgA tTG
antibodies); 2) or a proximal small intestinal biopsy compatible
with celiac disease; and 3) either clinical and/or histological
improvement with a gluten-free diet. The majority of cases fulfilled
all three criteria. A small proportion of subjects, predominantly
those diagnosed before modern serology came into use, did not
have celiac-specific serology, and another small minority of
subjects did not have a biopsy. Those who tested positive for
both IgA tTG and IgA EMA were considered positive for celiac
disease. Using this sequential testing technique, sensitivity and
specificity rates of virtually 100% were reported, making it
practical to accurately identify those with celiac disease on the
basis of serology alone [43,44]. A small biopsy was performed on
approximately 90% of those who tested positive serologically, and
all had a positive biopsy for the disease. For all sites, individuals
who were self-declared celiacs because of a self administered
gluten-free diet and without a biopsy, or individuals whose biopsy
demonstrated only minor changes such as increased intraepithelial
lymphocytes and/or crypt hyperplasia, were not included as cases.
The unaffected controls tested serologically negative for celiac
disease.
HLA typing
The process for determining the HLA-DQA1 and DQB1 alleles
in the cases and controls first involved determining the genotypes
of 95 of the individuals by Sanger sequencing. This set of 95
individuals acted as positive controls for the HLA genotyping of
the remaining case and control individuals. To identify controls for
genotyping for each of the HLA-DQA1 and DQB1 alleles, we
directly sequenced the second exons of DQA1 and DQB1 for 95
samples by Sanger sequencing using the ABI Prism BigDye
Terminator cycle sequencing kit 3.1 (PE Applied Biosystems).
Sequences were aligned using Sequencher software (GeneCode
Corporation, MI), as well as manually inspected if needed. DQ
allele assignments were done manually by comparing variants
from each sample to variants of each DQ allele downloaded from
dbMHC sequence alignment viewer (http://www.ncbi.nlm.nih.
gov/gv/mhc). Using those samples with DQ alleles determined by
direct sequencing, HLA-DQA1 and DQB1 genotypes were de-
termined by one of two high-throughput DQ typing methods.
Three hundred and eighty nine samples (from COH) were
genotyped by an allele-specific PCR method developed in our
laboratory by Feolo et al. [45]. Genotyping accuracy for this
method is greater than 98%. The remaining 1816 samples were
genotyped by a tagging SNPs approach in which six tagging SNPs
were used to predict four different HLA DQ types (DQ2.5,
DQ2.2, DQ7 and DQ8) associated with celiac disease [46].
Genotyping call rates ranged from 95% to 99% and duplicate
concordance rates were higher than 99%. There was 100%
concordance between the 95 HLA genotypes determined by
Sanger sequencing and the same individuals’ HLA genotypes
imputed from the six tagging SNPs.
Genotype data
A sample of 2300 individuals plus duplicates were genotyped at
the Center for Inherited Disease Research (CIDR) using the
Illumina 660 W Quad GWAS platform. Individuals and SNPs
with less than 98% complete GWAS genotype data were excluded
from the sample. SNPs with a minor allele frequency less than 0.03
or failing a test of Hardy-Weinberg equilibrium with a p-value less
than 1.0610
25 were excluded. GWAS genotype data were used to
test if data were consistent with second degree or higher familial
relationships and the reported sex, and inconsistencies that could
not be resolved resulted in sample exclusion. Analysis for
population stratification and admixture using multidemensional
scaling and cluster analysis revealed a predominant single cluster
and resulted in the exclusion of several apparent ancestral outliers.
A sample of 2185 individuals, including 1668 confirmed celiac
disease cases and 517 unaffected controls, passed all QC criteria,
had complete HLA typing information, and were used for
association analysis in the current study. There were 1898 SNPs
between positions 26,000,508 and 33,544,122 on chromsome 6p,
encompassing the xMHC that were part of the Illumina GWAS
panel, that passed all QC assessments and were used for the
current association analysis.
Conditional inference based recursive partitioning
A conditional inference-based recursive partitioning method
was used to partition the sample of individuals into strata based on
their HLA-DQA1 and HLA-DQB1 genotypes in such a way as to
minimize the within-group heterogeneity. The recursive partition-
ing method is a two-stage process in which predictor variables are
selected and then the sample is subjected to a binary split [47]. A
global test of independence between all the input variables and the
outcome was carried out to select independent predictor variables.
If the null hypothesis of independence could be rejected at a pre-
determined p-value threshold of 0.05, the input variable with the
strongest association to the response was selected. The extent of
association was measured by the p-value corresponding to a test of
the partial null hypothesis of a single input variable and the
response variable. A binary split was then imposed on the selected
input variable. These steps were repeated until the global null
hypothesis of independence could be rejected. A factor variable
was created from the terminal nodes of the tree resulting from the
binary splitting process. The terminal nodes define the set of strata
that each individual is assigned to based on their HLA-DQA1 and
HLA-DQB1 genotypes. The conditional inference based recursive
partitioning was computed using the PARTY package in R [48].
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Association analysis was performed by fitting logistic regression
models to the observed disease status and genotype data, with the
celiac disease outcome predicted by the SNP genotype. The
unphased genotypes 1/1, 1/2 and 2/2 were coded as 0, 1 or 2 to
denote the number of minor alleles present. HLA-DQA1 and HLA-
DQB1 effects on disease risk were accounted for by incorporating
the multi-level factor variable computed by recursive partitioning
into a multiple regression model with the SNP genotype. The
simple and multivariate regression models were computed using
PLINK and the GenABEL package in R [49,50].
Linkage disequilibrium (LD)-based SNP grouping
A data reduction procedure was used to group sets of SNPs that
had highly correlated associations with the celiac disease outcome
and to determine how many SNPs showing significant association
in the adjusted logistic regression were likely to be independent.
SNPs were grouped together into LD groups (or ‘clumps’) by rank
orders of p-values and decreasing LD, measured by r
2, from the
top or ‘index’ SNP in each group. In addition to an LD threshold
within each group, non-index SNPs also had to meet a specified
secondary p-value threshold and be within a physical distance
threshold (kb) from the index SNP. The LD-based SNP grouping
analysis was computed using the ‘clump’ procedure in PLINK
[50].
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